National Vision Holdings, Inc. EYE R2KR3K
Company Overview
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services. In addition, the company sells prescription and non-prescription eyewear, contact lenses and related accessories to retail customers. The company serves a diverse customer base, including price-driven consumers, style leaders, wellness shoppers with vision benefits, managed care customers, outside prescription customers, and progressive lens wearers. The company was formerly known as National Vision, Inc. and changed its name to National Vision Holdings, Inc. in March 2014. The company was founded in 1990 and is headquartered in Duluth, Georgia.
Why Investors Should Care
Net profit has compounded at 23.4% per year over the last five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jan 2026 Revenue of $1.99B (+9.0% YoY); net profit $29.60M.
- Trailing 12 Months Year-on-year growth — revenue +2.5%, earnings +36.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.5%, profit CAGR 23.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.46% |
| 1 Year: | 2.50% |
Compounded Profit Growth
| 5 Years: | 23.39% |
| 1 Year: | 36.40% |
Stock Price Performance
| 1 Year: | -19.60% |
| 6 Months: | -21.59% |
| 3 Months: | -9.98% |
| 1 Month: | +13.77% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)66.64 · Neutral
P/E of 30.11 is above the sector median of 18.27 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 23.4% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 36.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | EYE National Vision Holdings, Inc. R2KR3K | 18.67 | 30.11 | $1.48B | 0.00% | 3.74% | 5.76% | 6.46% | 23.39% |
| 2 | AMZN Amazon.com, Inc. NDXSPXR3KAITECH | 248.00 | 19.95 | $2.68T | 0.00% | 13.33% | 30.56% | 24.04% | 32.72% |
| 3 | TSLA Tesla, Inc. NDXSPXR3KAI | 372.22 | 351.15 | $1.47T | 0.00% | 4.10% | 4.67% | 52.40% | 39.39% |
| 4 | HD The Home Depot, Inc. SPXR3K | 319.83 | 22.40 | $319.09B | 3.08% | 28.75% | 104.30% | 4.06% | 6.35% |
| 5 | BABA Alibaba Group Holding Limited AITECH | 99.64 | 24.13 | $247.88B | 0.99% | 4.16% | 6.36% | 5.62% | 12.49% |
| 6 | TM Toyota Motor Corporation | 196.79 | 8.70 | $233.04B | 3.23% | 5.24% | 12.40% | 10.91% | 16.22% |
| 7 | MCD McDonald's Corporation SPXR3K | 248.46 | 20.20 | $175.82B | 2.99% | 22.47% | - | 0.92% | 7.33% |
| 8 | TJX The TJX Companies, Inc. SPXR3K | 145.06 | 26.86 | $160.25B | 1.52% | 21.26% | 62.17% | 6.84% | 8.48% |
| 9 | BKNG Booking Holdings Inc. NDXSPXR3K | 155.83 | 17.28 | $120.75B | 1.08% | 70.23% | -96.88% | 16.93% | 22.07% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Apr 2016 | Jul 2016 | Oct 2016 | Dec 2016 | Apr 2017 | Jul 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | Apr 2023 | Jul 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 369.86M | 337.54M | 346.09M | 321.82M | 407.98M | 385.53M | 387.43M | 355.92M | 461.21M | 429.45M | 431.90M | 401.76M | 469.70M | 260.01M | 485.35M | 534.18M | 549.49M | 518.00M | 527.71M | 509.56M | 499.21M | 464.81M | 431.79M | 438.82M | 420.95M | 482.79M | 451.73M | 451.51M | 437.28M | 510.32M | 486.42M | 487.33M | 543.88M |
| Operating Income | 39.69M | 15.74M | 14.31M | -3.35M | 39.02M | 13.06M | 15.82M | -3.61M | 38.85M | 24.97M | -2.08M | -19.39M | 32.40M | 21.70M | 11.11M | 8.36M | 16.91M | -41.60M | 54.79M | 61.45M | 54.83M | 50.71M | 37.33M | 18.37M | 15.36M | 27.80M | 5.56M | 3.55M | -12.42M | 23.44M | 591.00K | -8.82M | -25.57M | 26.14M | 16.45M | 9.61M | 45.24M |
| Net Income | 17.85M | 3.59M | 3.03M | -9.71M | 16.64M | -1.93M | 1.09M | 27.34M | 24.45M | 12.47M | 5.17M | -18.44M | 17.43M | 10.26M | 1.19M | 3.92M | 9.74M | -43.83M | 35.29M | 43.43M | 37.60M | 40.99M | 30.15M | 9.73M | 11.50M | 18.27M | 5.61M | -73.80M | -15.99M | 11.69M | -3.12M | -8.47M | -28.59M | 14.19M | 8.72M | 3.37M | 31.18M |
| Diluted EPS | 0.32 | 0.06 | 0.05 | -0.17 | 0.29 | -0.03 | 0.02 | 0.37 | 0.31 | 0.16 | 0.06 | -0.24 | 0.21 | 0.13 | 0.01 | 0.05 | 0.12 | -0.55 | 0.42 | 0.48 | 0.42 | 0.45 | 0.34 | 0.12 | 0.15 | 0.20 | 0.07 | -0.94 | -0.20 | 0.15 | -0.04 | -0.11 | -0.36 | 0.18 | 0.11 | 0.04 | 0.38 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.06B | 1.20B | 1.38B | 1.54B | 1.72B | 1.71B | 2.08B | 1.64B | 1.76B | 1.82B | 1.99B |
| Operating Income | 44.68M | 64.07M | 64.29M | 42.35M | 73.58M | 87.01M | 174.94M | 52.77M | 24.49M | -10.36M | 58.83M |
| Net Income | 3.62M | 13.34M | 43.14M | 23.65M | 32.80M | 36.28M | 128.24M | 42.12M | -65.90M | -28.50M | 29.60M |
| Diluted EPS | 0.06 | 0.23 | 0.70 | 0.30 | 0.40 | 0.44 | 1.43 | 0.52 | -0.84 | -0.36 | 0.37 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jan 2015 | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.53B | 1.58B | 1.66B | 2.03B | 2.33B | 2.29B | 2.29B | 2.17B | 2.01B | 1.98B |
| Total Equity | 523.59M | 385.34M | 399.58M | 654.60M | 743.15M | 776.44M | 906.50M | 925.98M | 901.11M | 829.42M | 816.33M | 869.53M |
| Cash & Equivalents | 6.83M | 5.59M | 4.95M | 4.21M | 17.13M | 39.34M | 373.90M | 305.80M | 229.43M | 149.90M | 73.95M | 38.71M |
| Long Term Debt | - | - | - | - | - | 525.90M | 624.61M | 543.57M | 546.23M | 437.68M | 239.15M | 223.24M |
| Current Liabilities | - | - | 199.68M | 211.31M | 211.65M | 273.18M | 328.68M | 343.80M | 344.26M | 397.70M | 468.27M | 412.41M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 83.13M | 97.59M | 90.25M | 106.63M | 165.08M | 234.98M | 258.94M | 119.20M | 173.03M | 133.65M | 146.29M |
| Investing Cash Flow | -80.05M | -90.97M | -94.58M | -104.22M | -100.63M | -76.41M | -92.90M | -110.89M | -115.82M | -96.09M | -76.61M |
| Financing Cash Flow | -4.32M | -6.57M | 3.84M | 10.40M | -42.14M | 176.28M | -234.32M | -84.56M | -136.81M | -113.34M | -104.62M |
| Capital Expenditure | -77.16M | -90.03M | -93.22M | -104.49M | -101.33M | -76.82M | -95.52M | -113.55M | -114.77M | -95.50M | -72.84M |
| Free Cash Flow | 5.97M | 7.56M | -2.97M | 2.13M | 63.76M | 158.16M | 163.42M | 5.65M | 58.26M | 38.14M | 73.45M |
| Share Buybacks | - | 188.00K | 0 | 1.93M | 25.65M | 689.00K | 73.30M | 84.39M | 28.41M | 3.09M | 3.21M |
| Dividends Paid | 145.67M | 0 | 170.98M | 0 | 0 | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jan 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 4.2% | 5.4% | 4.7% | 2.8% | 4.3% | 5.1% | 8.4% | 3.2% | 1.4% | -0.6% | 3.0% |
| Net Margin % | 0.3% | 1.1% | 3.1% | 1.5% | 1.9% | 2.1% | 6.2% | 2.6% | -3.8% | -1.6% | 1.5% |
| ROE % | 0.9% | 3.3% | 6.6% | 3.2% | 4.2% | 4.0% | 13.8% | 4.7% | -7.9% | -3.5% | 3.4% |
| ROCE % | - | 4.8% | 4.7% | 2.9% | 4.2% | 4.3% | 9.0% | 2.7% | 1.4% | -0.7% | 3.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.32% | 12.11M | $202.07M |
| 2 | Wellington Management Group, LLP | 9.70% | 7.67M | $127.93M |
| 3 | Vanguard Portfolio Management LLC | 6.87% | 5.43M | $90.62M |
| 4 | William Blair Investment Management, LLC | 6.00% | 4.75M | $79.19M |
| 5 | FMR, LLC | 5.15% | 4.07M | $67.89M |
| 6 | Engine Capital Management, LP | 4.45% | 3.52M | $58.73M |
| 7 | State Street Corporation | 4.38% | 3.47M | $57.80M |
| 8 | Vanguard Capital Management LLC | 4.30% | 3.40M | $56.71M |
| 9 | Dimensional Fund Advisors LP | 4.28% | 3.38M | $56.46M |
| 10 | Ameriprise Financial, Inc. | 3.98% | 3.15M | $52.52M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EYE
1 profitable stock to keep an eye on and 2 facing challenges - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPcTJJa1d0WXFFSUVHZ2EyYURoSHVEOENKMUoxZjJfTFZfRi0xQXVZczRLNjZfZWdsbm1zdW5jcTZLNDFqOVhVZnZMYkJGWEpsLTNWWnJUUk9RaGtYdk0wZjRCbUM3X25mejdmWnlwVFB1RDZaWW16V3gzNFdaaW9TNURKTnlJZ1FHZU0weX…
EyePoint Stock Sinks 82% After Key Eye Drug Fails and Staff Is Slashed. Strategy Shift’s Success Is ‘Pretty Debatable.’ - Barron's
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNeHF4Y1UwdTVyLTcyLUp4U0g5TVgzb3NrX3Q1dlRpY2FVTEIyeG9ZRVZ0MjlUWUszdjN1d3VXUDVnUlpHQ1F0Qk9CZUFoUERQb1o2TEFNTWI0a2NlUDZNZmxFSzUydDdLS1VxM3VMWUxJOTdvNERURWd4amNoTGxkdmpuN1VLaDA?oc=5" …
1 large-cap stock to keep an eye on and 2 we brush off - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxORDk5Q0xKVFdWdWJ1VkJKUEZFVTA3cFNvVlRoUEZDZWpHd3VWbWxLWkEyaFdwbUNXQlJMcVM5QWJBWU9vemE2WDhmeklQRS1Ob0YtM1l5RFFWQTRZMDkxdXlqLWtaNHpUYlJHbnMxa2t1RkJJYjc4bnFaek5sLXZaN3lrajJ1QlRnU3pUOG…
I’m Buying This Health Care Stock as Traders Eye Tech Exit - TheStreet Pro
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQSGpFMFRpWDZReXhvSmcyTmJxRVRyT3dvWGpfVFRaUXZwblI4aElsY3VHNUdpZ1o0Z0thcXZWeFVTWEQ3Z0VsZklEWkdRMGhRekpjSEJXMVRwMzB3RGI1REpfaE1MZmlUbDNROTFuUFlUdEZ6OHRwX215WkxqQW9LVXRfbk9yRWFHWjExWE…
Jaguars Stock Report: 3 Risers, 3 Fallers After Week 6's Eye-Opening Texans Loss - Sports Illustrated
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQWXdNNXJoQVlkeW9DM1Y5UmVqREVyYVZHNVZadXJNb016eDRNNFhtVlc5SnBLNmVrbnFVaXJSZy1JNjBoc2hsZXNpQUQyQVpfV3Z4TEV5Wno2VDFCZUpHUzU4QjNaLXVvM0FkX1ZiTGNoT2EwUDlkWHpVN1VtY25teWd3cjQ2ZlNFNXVsWG…
EyePoint: Stock Takes Shellacking On Second Pivotal Eye Disease Study Miss (NASDAQ:EYPT) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOU0Jkcm84Tm56SXMxZ1NWcnJXSGsybGV3cmVoTWVnenFEd0RQLTdKSFMtODBpbFBMMUl6bzVkRGt4UUtKUHhMejBxeFpiXzlJWlhYRUVGTHZKVFJHdmM0dmxJR1YzYXRjY0puenF1cXFiYjlYSlpETVo3c3hIc0o0TDJnaFFncnRhSDZSYT…
EYE — Frequently Asked Questions
What is the current share price of National Vision Holdings, Inc. (EYE)?
As of 2026-10-23 16:27 PDT, National Vision Holdings, Inc. (EYE) trades at $18.67 on NasdaqGS. Its 52-week range is $15.44 to $29.46.
What is the market capitalisation of EYE?
National Vision Holdings, Inc. (EYE) has a market capitalisation of $1.48B on NasdaqGS.
What is the P/E ratio of EYE?
EYE trades at a trailing price-to-earnings (P/E) ratio of 30.11. The industry average P/E is 18.27. Its price-to-book (P/B) ratio is 1.47.
What is the return on equity (ROE) of EYE?
EYE has a return on equity (ROE) of 5.76%. Its return on capital employed (ROCE) is 3.74%.
Is EYE a good stock to buy?
This page provides a data-driven analysis of National Vision Holdings, Inc. (EYE), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.